Overview

Safety and Effect of Pertuzumab in Patients With Advanced Non-Small Cell Lung Cancer, Which Has Progressed After Prior Chemotherapy

Status:
Completed

Trial end date:
2005-04-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine if the study drug pertuzumab is effective in treating patients with advanced lung cancer that has recurred following prior chemotherapy.

Phase:

Phase 2

Details

Lead Sponsor:

Genentech, Inc.

Treatments:

Pertuzumab